Evia Life Sciences: Funding, Investors & Team (Nov 2026)
EVIA Life Sciences is a biotechnology company that develops cell-free exosome-based therapeutics targeting liver fibrosis and MASH.
Evia Life Sciences has raised $700k across 1 funding round on record, the most recent a Seed of $700k announced in Nov 2026.
That round is below the $3.3M median round size for Japan companies tracked on FundedIQ over the last two years.
Evia Life Sciences Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Evia Life Sciences Funding Rounds
Evia Life Sciences Funding in Context
Evia Life Sciences' latest round of $700k is below the median round in Japan. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evia Life Sciences in Biotechnology and Tokyo
Companies Similar to Evia Life Sciences
Tailored peptide antigens and potent adjuvant formulation drive powerful and specific anti-cancer T cell…
ABLE Labs is a biotechnology company that develops laboratory automation and liquid-handling solutions for…
Smartround is a finance management platform for startups and their investors and streamlines fundraising for…
FactBase specializes in DX's promotion of small and medium-sized enterprises that can support japan's…
Pay2o is a payment service specializing in recurring payments such as monthly fees and membership fees.
Quadlytics is a medical manufacturing company that develops medical equipment, software development, and data…
Openrec is a live-streaming platform that focuses on game commentary and online event business.
Atomic Software is a work efficiency software that can combine the disjointed free medical care clinic work…
BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities.
Green Growth Co. is an infrastructure-creation startup that provides renewable energy development and…
Ideable Works is a company that provides a platform which helps artists to work on their creative activities.
Crosssector provides sensor DX solutions for various kinds of construction and maintenance applications.
Evia Life Sciences Funding FAQs
What does Evia Life Sciences do?
EVIA Life Sciences is a biotechnology company that develops cell-free exosome-based therapeutics targeting liver fibrosis and MASH.
How much funding has Evia Life Sciences raised?
Evia Life Sciences has raised $700k across 1 round on record. The most recent is a Seed of $700k announced in Nov 2026.
When did Evia Life Sciences last raise funding?
Evia Life Sciences' most recent funding round on record is a Seed of $700k, announced in Nov 2026.
Where is Evia Life Sciences headquartered?
Evia Life Sciences is based in Tokyo, Japan.
About FundedIQ's Evia Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evia Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.